S

Sanofi

Global pharma company; vaccines and R&D

iSHIFT Solution Delivery - Vistex Trade Expert

Full-TimeDeadline 11/6/26
€59.6k - €89.4k
Senior, Expert
Bachelor's
Barcelona, Spain
Hybrid
IT OperationsEnterprise Applications

About the job

Requirements
  • A university degree in economics, engineering, computer science, or a comparable field is required.
  • At least 8 years of Vistex/SAP experience is required.
  • At least 3 full-lifecycle Vistex implementations across all phases are required.
  • At least 8 years of experience designing and configuring Vistex domains such as Rebates Management, Incentive and Commission Management, Pricing, or Chargebacks and Billbacks is required.
  • Proficient knowledge of SAP Pricing solutions, including pricing procedures, condition contracts, settlement management, customer rebates, and integration between Sales and Distribution and Finance/Controlling, is required.
  • Demonstrated experience with Vistex modules, including Rebate Management components such as Rebate Agreements, Calculation Buckets, Accrual Profiles, and Settlement Documents; Incentive and Commission Management components such as Commission Agreements, Incentive Plans/Quotas, Target Profiles, Territory/Hierarchy Objects, Calculation Buckets, and Settlement Documents; Price Management components such as Pricing Agreements, Deal Sheets, Price Proposals, Price Sheets, dynamic Condition Records, and pricing simulation; or Chargebacks and Billbacks components such as Agreements, Claims/Sales Tracing data, Calculation Buckets, Claim Validation Rules, and Settlement Documents, is required.
  • Experience and good knowledge in analysis and design of Trade business processes is required; pharmaceutical or similar industry experience is ideal.
  • Experience with Master Data, IDocs/BAPIs, and interfacing SAP with legacy applications is required.
  • Proven experience working in major IT consulting firms as a stream lead or functional expert is required.
  • International SAP project experience is required.
  • Proficiency with Microsoft Office and information systems tools is required.
  • Agile methodology experience is required.
  • SAP technical skills and a fair understanding of core SAP technical topics, including debugging, Fiori UX, and batch jobs, are required.
  • Strong analytical ability to formalize solutions, write clearly, and analyze and resolve user issues related to system design, process flows, and SAP configuration while considering impacts on other systems is required.
  • Fluency in English is required.
  • Strong oral and written communication skills and the ability to challenge requirements and convince stakeholders are required.
  • The candidate must be rigorous and autonomous and demonstrate accountability and reliability.
Responsibilities
  • Lead or contribute to scoping studies.
  • Provide workload estimates for new Sales and Distribution scope or new functionality to be implemented as part of continuous improvement.
  • Lead Global Design or Fit-Gap workshops with the Business Enablement team to design solutions based on industry best practices and GBU and Global Support Functions business needs.
  • Define and drive implementation of the Trade global template and ensure its ongoing governance and evolution.
  • Propose suitable SAP solutions that minimize gaps with standard functionality by challenging business requirements, and specify agreed solutions for customization and development.
  • Perform impact analysis for application changes involving S4HANA and satellite applications such as Sales Force Automation tools and e-commerce platforms.
  • Contribute to transversal-stream design, including master data management and migration strategy, analytics, authorizations, process controls, and integration topics with other Solution Delivery domains.
  • Collect and consolidate Trade information needed to define the infrastructure and application landscape, and ensure Trade solutions align with enterprise architecture standards and principles.
  • Deliver all program design deliverables under Solution Delivery responsibility, including solution documents and functional specifications.
  • Develop expertise in new SAP S4HANA capabilities within the assigned scope and contribute to continuous improvement through proofs of concept.
  • Organize, complete, unit-test, and document system configuration.
  • Contribute to specific developments with the development team, including functional-specification updates and unit-test inputs.
  • Ensure development quality, contribute to audits and quality KPI follow-up, identify S4HANA product or project issues, and work with the project partner to resolve them.
  • Organize, document, and execute integration and system tests.
  • Contribute to user acceptance testing and finalize the solution by addressing identified defects.
  • Use documentation and testing tools as defined by the iShift Program.
  • Complete program deliverables under Solution Delivery responsibility, including test protocols and test reports.
  • Contribute to Trade-stream migration activities.
  • Document and execute Trade-stream cutover activities.
  • Update training documents and contribute to training on Trade solutions.
  • Provide go-live support and hypercare activities.
  • Lead the Trade project transition to AMS, including knowledge-transfer sessions and handover of ongoing incidents.
  • Contribute to AMS activities by providing functional expertise on complex topics and challenging or validating solution evolutions proposed by the AMS team.
  • Liaise with the support partner to resolve SAP functional and technical issues.
  • Serve as the referent expert for specific Sales and Distribution topics by providing ad hoc support to projects during the design phase and validating evolutions.
  • Keep reference documentation up to date.
  • Contribute to continuous improvement by keeping informed about new Trade and Sales functionality and contributing to proofs of concept and prototypes.
  • Learn and develop expertise in current and new S4HANA products and solution offerings.
Desired Qualifications
  • Knowledge of other SAP functional domains is an advantage.
  • Experience analyzing and designing Trade business processes in the pharmaceutical or a similar industry is ideal.
  • Knowledge of Agile project methodologies is a plus.
  • Fluency in any language in addition to English is a plus.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • Parental Leave

Company News

Associated Press
Oct 19th, 2026
Enable Injections wins first Japan approval for enFuse on-body injector via Sanofi's CirCLIQ

Enable Injections has won its first commercial product approval in Japan. The country's Ministry of Health, Labour and Welfare approved the company's enFuse On-Body Delivery System through Sanofi's CirCLIQ Injector. The device delivers a subcutaneous form of Sarclisa (isatuximab) with the push of a button, for treating multiple myeloma. It is the first anticancer treatment given through an on-body injector in Japan. The approval follows recent clearances in the US and Europe. Japan approved Sarclisa SC in June 2026, backed by the IRAKLIA phase 3 study, which showed the subcutaneous form was non-inferior to intravenous delivery. "We're proud to partner with Sanofi to bring our enFuse technology to patients in Japan," said Michael D. Hooven, chairman and chief executive officer of Enable.

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...